{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:34:43Z","timestamp":1786376083077,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00705-020-04606-6","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T08:03:25Z","timestamp":1586592205000},"page":"1453-1461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017\u20132019)"],"prefix":"10.1007","volume":"165","author":[{"given":"Zhaojie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,11]]},"reference":[{"key":"4606_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). World Health Organization. https:\/\/www.unaids.org\/en\/resources\/documents\/2019\/aids-by-the-numbers"},{"issue":"8","key":"4606_CR2","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/01.aids.0000304710.10036.2b","volume":"21","author":"F Zhang","year":"2007","unstructured":"Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D et al (2007) The Chinese free antiretroviral treatment program: challenges and responses. AIDS (London, England) 21(8):S143\u2013S148","journal-title":"AIDS (London, England)"},{"issue":"3","key":"4606_CR3","first-page":"184","volume":"11","author":"Y Ma","year":"1990","unstructured":"Ma Y, Li Z, Zhang K et al (1990) HIV was first discovered among injection drug users in China. Chin J Epidemiol 11(3):184\u2013185","journal-title":"Chin J Epidemiol"},{"key":"4606_CR4","doi-asserted-by":"crossref","unstructured":"Li G, Jiang Y, Zhang L (2019) HIV upsurge in China's students. American Association for the Advancement of Science","DOI":"10.1126\/science.aay0799"},{"issue":"5","key":"4606_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5582\/bst.2018.01269","volume":"12","author":"Q Tang","year":"2018","unstructured":"Tang Q, Lu HZ (2018) HIV\/AIDS responses in China should focus on the impact of global integration. Biosci Trends 12(5):507\u2013509","journal-title":"Biosci Trends"},{"issue":"5463","key":"4606_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.288.5463.55d","volume":"288","author":"DL Robertson","year":"2000","unstructured":"Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK et al (2000) HIV-1 nomenclature proposal. Science 288(5463):55\u201357","journal-title":"Science"},{"issue":"1","key":"4606_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1473-3099(10)70186-9","volume":"11","author":"DM Tebit","year":"2011","unstructured":"Tebit DM, Arts EJ (2011) Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 11(1):45\u201356","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"4606_CR8","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1017\/S0950268816000212","volume":"144","author":"R Yuan","year":"2016","unstructured":"Yuan R, Cheng H, Chen LS, Zhang X, Wang B (2016) Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis. Epidemiol Infect 144(10):2144\u20132153","journal-title":"Epidemiol Infect"},{"issue":"13","key":"4606_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella","year":"1998","unstructured":"Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13):853\u2013860","journal-title":"N Engl J Med"},{"issue":"2","key":"4606_CR10","first-page":"89","volume":"19","author":"B Chimukangara","year":"2017","unstructured":"Chimukangara B, Samuel R, Naidoo K, de Oliveira T (2017) Primary HIV-1 drug resistant minority variants. AIDS Rev 19(2):89\u201396","journal-title":"AIDS Rev"},{"issue":"3","key":"4606_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.qai.0000197070.69859.f3","volume":"41","author":"JA Bartlett","year":"2006","unstructured":"Bartlett JA, Buda JJ, von Scheele B, Mauskopf JA, Davis EA, Elston R et al (2006) Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview. J Acquir Immune Defic Syndr (1999) 41(3):323\u2013331","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"5","key":"4606_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/01.aids.0000162337.58557.3d","volume":"19","author":"AN Phillips","year":"2005","unstructured":"Phillips AN, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti AM et al (2005) Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS (London, England) 19(5):487\u2013494","journal-title":"AIDS (London, England)"},{"issue":"16","key":"4606_CR13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/archinte.167.16.1782","volume":"167","author":"V von Wyl","year":"2007","unstructured":"von Wyl V, Yerly S, B\u00f6ni J, B\u00fcrgisser P, Klimkait T, Battegay M et al (2007) Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med 167(16):1782\u20131790","journal-title":"Arch Intern Med"},{"issue":"6","key":"4606_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJMoa013552","volume":"347","author":"SJ Little","year":"2002","unstructured":"Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC et al (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347(6):385\u2013394","journal-title":"N Engl J Med"},{"issue":"5","key":"4606_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/135965350400900514","volume":"9","author":"D Pillay","year":"2004","unstructured":"Pillay D (2004) Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe. Antivir Ther 9(5):695\u2013702","journal-title":"Antivir Ther"},{"issue":"1","key":"4606_CR16","doi-asserted-by":"publisher","first-page":"e0209605","DOI":"10.1371\/journal.pone.0209605","volume":"14","author":"P Machnowska","year":"2019","unstructured":"Machnowska P, Meixenberger K, Schmidt D, Jessen H, Hillenbrand H, Gunsenheimer-Bartmeyer B et al (2019) Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort. PLoS ONE 14(1):e0209605","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"4606_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0166-0934(01)00272-5","volume":"94","author":"C Pasquier","year":"2001","unstructured":"Pasquier C, Millot N, Njouom R, Sandres K, Cazabat M, Puel J et al (2001) HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 94(1\u20132):45\u201354","journal-title":"J Virol Methods"},{"issue":"5","key":"4606_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.coviro.2012.08.006","volume":"2","author":"RJ Lessells","year":"2012","unstructured":"Lessells RJ, Katzenstein DK, de Oliveira T (2012) Are subtype differences important in HIV drug resistance? Curr Opin Virol 2(5):636\u2013643","journal-title":"Curr Opin Virol"},{"key":"4606_CR19","unstructured":"Fund Global, World Health Organization (2017) HIV drug resistance report 2017: World Health Organization"},{"issue":"7","key":"4606_CR20","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1128\/JVI.73.7.6099-6103.1999","volume":"73","author":"SR Lewin","year":"1999","unstructured":"Lewin SR, Vesanen M, Kostrikis L, Hurley A, Markowitz M (1999) Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol 73(7):6099\u20136103","journal-title":"J Virol"},{"issue":"6","key":"4606_CR21","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1021\/ac802267u","volume":"81","author":"BC Kim","year":"2009","unstructured":"Kim BC, Ju MK, Dan-Chin-Yu A, Sommer P (2009) Quantitative detection of HIV-1 particles using HIV-1 neutralizing antibody-conjugated beads. Anal Chem 81(6):2388\u20132393","journal-title":"Anal Chem"},{"issue":"1\u20132","key":"4606_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0166-0934(00)00288-3","volume":"93","author":"BK Saha","year":"2001","unstructured":"Saha BK, Tian B, Bucy RP (2001) Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe. J Virol Methods 93(1\u20132):33\u201342","journal-title":"J Virol Methods"},{"issue":"9171","key":"4606_CR23","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","volume":"353","author":"J Durant","year":"1999","unstructured":"Durant J, Clevenbergh P, Halfon P, Delgiudice P, Porsin S, Simonet P et al (1999) Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet (London, England) 353(9171):2195\u20132199","journal-title":"Lancet (London, England)"},{"issue":"9","key":"4606_CR24","doi-asserted-by":"publisher","first-page":"F83","DOI":"10.1097\/00002030-200006160-00001","volume":"14","author":"JD Baxter","year":"2000","unstructured":"Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Hoover ML, Winters MA et al (2000) A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. AIDS (London, England). 14(9):F83\u201393","journal-title":"AIDS (London, England)."},{"issue":"4","key":"4606_CR25","doi-asserted-by":"publisher","first-page":"e61864","DOI":"10.1371\/journal.pone.0061864","volume":"8","author":"F Jahanbakhsh","year":"2013","unstructured":"Jahanbakhsh F, Hattori J, Matsuda M, Ibe S, Monavari SH, Memarnejadian A et al (2013) Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011. PLoS ONE 8(4):e61864","journal-title":"PLoS ONE"},{"issue":"3","key":"4606_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/aid.2008.0219","volume":"25","author":"RM Lynch","year":"2009","unstructured":"Lynch RM, Shen T, Gnanakaran S, Derdeyn CA (2009) Appreciating HIV type 1 diversity: subtype differences in Env. AIDS Res Hum Retrovir 25(3):237\u2013248","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"4606_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ympev.2011.11.019","volume":"62","author":"E Castro-Nallar","year":"2012","unstructured":"Castro-Nallar E, P\u00e9rez-Losada M, Burton GF, Crandall KA (2012) The evolution of HIV: inferences using phylogenetics. Mol Phylogenet Evol 62(2):777\u2013792","journal-title":"Mol Phylogenet Evol"},{"issue":"10","key":"4606_CR28","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10):2731\u20132739","journal-title":"Mol Biol Evol"},{"issue":"5","key":"4606_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1179\/2295333714Y.0000000038","volume":"69","author":"S Megens","year":"2014","unstructured":"Megens S, De Wit S, Bernatchez J, Dekeersmaeker N, Vinken L, Covens K et al (2014) Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase. Acta Clin Belg 69(5):348\u2013357","journal-title":"Acta Clin Belg"},{"issue":"21","key":"4606_CR30","doi-asserted-by":"publisher","first-page":"10747","DOI":"10.1128\/JVI.01827-07","volume":"82","author":"Y Mitsuya","year":"2008","unstructured":"Mitsuya Y, Varghese V, Wang C, Liu TF, Holmes SP, Jayakumar P et al (2008) Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations. J Virol 82(21):10747\u201310755","journal-title":"J Virol"},{"issue":"5","key":"4606_CR31","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1128\/AAC.05487-11","volume":"56","author":"GL Melikian","year":"2012","unstructured":"Melikian GL, Rhee SY, Taylor J, Fessel WJ, Kaufman D, Towner W et al (2012) Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility. Antimicrob Agents Chemother 56(5):2305\u20132313","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4606_CR32","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1097\/01.aids.0000237367.56864.75","volume":"20","author":"B Berkhout","year":"2006","unstructured":"Berkhout B, Back NK, de Ronde A, Jurriaans S, Bakker M, Parkin NT et al (2006) Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase. AIDS (London, England) 20(11):1515\u20131520","journal-title":"AIDS (London, England)"},{"issue":"11","key":"4606_CR33","doi-asserted-by":"publisher","first-page":"e1002432","DOI":"10.1371\/journal.pmed.1002432","volume":"14","author":"AJ Szubert","year":"2017","unstructured":"Szubert AJ, Prendergast AJ, Spyer MJ, Musiime V, Musoke P, Bwakura-Dangarembizi M et al (2017) Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: observational analyses within the randomised ARROW trial. PLoS Med 14(11):e1002432","journal-title":"PLoS Med"},{"issue":"5","key":"4606_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199807303390504","volume":"339","author":"FM Hecht","year":"1998","unstructured":"Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H et al (1998) Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med 339(5):307\u2013311","journal-title":"N Engl J Med"},{"issue":"6","key":"4606_CR35","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1086\/516487","volume":"175","author":"A Imrie","year":"1997","unstructured":"Imrie A, Beveridge A, Genn W, Vizzard J, Cooper DA (1997) Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. J Infect Dis 175(6):1502\u20131506","journal-title":"J Infect Dis"},{"issue":"9180","key":"4606_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(98)12262-6","volume":"354","author":"S Yerly","year":"1999","unstructured":"Yerly S, Kaiser L, Race E, Bru J, Clavel F, Perrin L (1999) Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet 354(9180):729\u2013733","journal-title":"Lancet"},{"issue":"7","key":"4606_CR37","doi-asserted-by":"publisher","first-page":"502","DOI":"10.7326\/0003-4819-131-7-199910050-00004","volume":"131","author":"SK Brodine","year":"1999","unstructured":"Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK et al (1999) Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 131(7):502\u2013506","journal-title":"Ann Intern Med"},{"issue":"10","key":"4606_CR38","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/j.ijid.2011.05.013","volume":"15","author":"LM Luft","year":"2011","unstructured":"Luft LM, Gill MJ, Church DL (2011) HIV-1 viral diversity and its implications for viral load testing: review of current platforms. Int J Infect Dis 15(10):e661\u2013e670","journal-title":"Int J Infect Dis"},{"issue":"10","key":"4606_CR39","doi-asserted-by":"publisher","first-page":"e75777","DOI":"10.1371\/journal.pone.0075777","volume":"8","author":"L Li","year":"2013","unstructured":"Li L, Sun G, Liang S, Li J, Li T, Wang Z et al (2013) Different distribution of HIV-1 subtype and drug resistance were found among treatment na\u00efve individuals in Henan, Guangxi, and Yunnan province of China. PLoS ONE 8(10):e75777","journal-title":"PLoS ONE"},{"issue":"10","key":"4606_CR40","doi-asserted-by":"publisher","first-page":"e47289","DOI":"10.1371\/journal.pone.0047289","volume":"7","author":"X He","year":"2012","unstructured":"He X, Xing H, Ruan Y, Hong K, Cheng C, Hu Y et al (2012) A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS ONE 7(10):e47289","journal-title":"PLoS ONE"},{"issue":"2","key":"4606_CR41","doi-asserted-by":"publisher","first-page":"e89291","DOI":"10.1371\/journal.pone.0089291","volume":"9","author":"Y Bao","year":"2014","unstructured":"Bao Y, Tian D, Zheng YY, Xi HL, Liu D, Yu M et al (2014) Characteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province, China. PLoS ONE 9(2):e89291","journal-title":"PLoS ONE"},{"issue":"11\u201312","key":"4606_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/sj.cr.7290356","volume":"15","author":"JY Li","year":"2005","unstructured":"Li JY, Li HP, Li L, Li H, Wang Z, Yang K et al (2005) Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 15(11\u201312):843\u2013849","journal-title":"Cell Res"},{"issue":"11","key":"4606_CR43","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.3390\/v2112493","volume":"2","author":"MA Wainberg","year":"2010","unstructured":"Wainberg MA, Brenner BG (2010) Role of HIV subtype diversity in the development of resistance to antiviral drugs. Viruses 2(11):2493\u20132508","journal-title":"Viruses"},{"issue":"undefined","key":"4606_CR44","first-page":"256982","volume":"2012","author":"MA Wainberg","year":"2012","unstructured":"Wainberg MA, Brenner BG (2012) The impact of HIV genetic polymorphisms and subtype differences on the occurrence of resistance to antiretroviral drugs. Mol Biol Int 2012(undefined):256982","journal-title":"Mol Biol Int"},{"issue":"9","key":"4606_CR45","first-page":"1081","volume":"122","author":"J Li","year":"2009","unstructured":"Li J, Li L, Li HP, Zhuang DM, Liu SY, Liu YJ et al (2009) Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations. Chin Med J 122(9):1081\u20131086","journal-title":"Chin Med J"},{"issue":"1","key":"4606_CR46","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/QAI.0b013e3181c7d363","volume":"53","author":"L Liao","year":"2010","unstructured":"Liao L, Xing H, Shang H, Li J, Zhong P, Kang L et al (2010) The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. J Acquir Immune Defic Syndr (1999) 53(1):S10\u2013S14","journal-title":"J Acquir Immune Defic Syndr (1999)"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-020-04606-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:58:37Z","timestamp":1744178317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-020-04606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4606"],"URL":"https:\/\/doi.org\/10.1007\/s00705-020-04606-6","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,11]]},"assertion":[{"value":"12 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Ethics Committee of The Sixth People\u2019s Hospital of Zhengzhou, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Signed informed consent was obtained from each patient before the collection of blood samples.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}